Cargando…
Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease
BACKGROUND: Metabolic acidosis accelerates progression of chronic kidney disease, but whether this is also true for autosomal dominant polycystic kidney disease (ADPKD) is unknown. METHODS: Patients with ADPKD from the DIPAK (Developing Interventions to halt Progression of ADPKD) trial were included...
Autores principales: | Blijdorp, Charles J, Severs, David, Musterd-Bhaggoe, Usha M, Gansevoort, Ronald T, Zietse, Robert, Hoorn, Ewout J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643593/ https://www.ncbi.nlm.nih.gov/pubmed/33377160 http://dx.doi.org/10.1093/ndt/gfaa283 |
Ejemplares similares
-
Thiazide diuretics and the rate of disease progression in autosomal dominant polycystic kidney disease: an observational study
por: Kramers, Bart J, et al.
Publicado: (2020) -
Somatostatin in renal physiology and autosomal dominant polycystic kidney disease
por: Messchendorp, A Lianne, et al.
Publicado: (2019) -
Drugs in Clinical Development to Treat Autosomal Dominant Polycystic Kidney Disease
por: Bais, Thomas, et al.
Publicado: (2022) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)